✦ LIBER ✦

Sequential endocrine therapy and chemotherapy in metastatic breast cancer: Effects on survival

✍ Scribed by Andrea Manni; Olof H. Pearson; James S. Marshall; Bahauddin M. Arafah

Publisher: Springer US
Year: 1981
Tongue: English
Weight: 651 KB
Volume: 1
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01805861

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of prior adjuvant chemotherap

The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer

✍ Frederick R. Ahmann; Stephen E. Jones; Thomas E. Moon 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 550 KB

Some adjuvantly treated patients develop recurrent breast cancer and little is known about the effect of prior adjuvant chemotherapy on subsequent response rates to systemic therapy or on overall survival. We describe our retrospective comparison of 179 patients who received doxorubicin containing a

Metastatic breast cancer in males assess

Metastatic breast cancer in males assessment of endocrine therapy

✍ Jashbhai K. Patel; Takuma Nemoto; Thomas L. Dao 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 3 views

22 men with metastatic breast cancer were treated with endocrine therapy. All 22 patients were initially treated by bilateral orchiectomy, and objective response was seen in 11 (50%) patients for 15 months. Bilateral adrenalectomy was performed subsequently in 10 patients, and 8 (80%) patients had a

Relationship between steroid receptors a

Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer

✍ Peter C. M. Young; Clarence E. Ehrlich; Lawrence H. Einhorn 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB 👁 3 views

Metastatic pattern and response to endoc

Metastatic pattern and response to endocrine therapy in human breast cancer

✍ Claus Kamby; Carsten Rose 📂 Article 📅 1986 🏛 Springer US 🌐 English ⚖ 630 KB

Cyclic and sequential therapy with tamox

Cyclic and sequential therapy with tamoxifen and medroxyprogesterone acetate in metastatic breast cancer

✍ Takuma Nemoto; Dr. Jashbhai K. Patel; Dutzu Rosner; Thomas L. Dao; H. Halvorson 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

A clinical trial of sequential tamoxifen and medroxyprogesterone acetate (MPA) was carried out in 36 women with metastatic breast cancer in order to evaluate the therapeutic efficacy of this regimen and to determine if tamoxifen would increase progesterone receptor (PR) levels and thereby increase r

Chemotherapy versus combination of chemo

Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer: A prospective randomized study

✍ G. Cocconi; V. de Lisi; C. Boni; P. Mori; P. Malacarne; D. Amadori; E. Giovanell 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB